Genmab — Oktober 2020

[GeorgeBest]

1099M USD

[GeorgeBest]

Bedre end consensus

[E_L]

excellent

[E_L]

better as my forecast

[E_L]

big landmark > 1bn $ quarter

[BioShare]

USD 1,099 million in the third quarter of 2020. Net trade sales were USD 585 million in the U.S. and USD 514 million in the rest of the world.

[Bulder]

also better than mine

[Bulder]

No problem reaching +4bn

[kkjoel]

sc is really making an impact, huh?!

[Bulder]

Us up 19%!

[kkjoel]

sc kan vise sig at være en langt vigtigere konkurranceparameter end nogen havde turdet forestille sig!
(undtagen JvW og McJean, naturligvis

[AaBforever]

DK -0,04%

[AaBforever]

Så er jeg mere rolig..:-D

[Bulder]

Det tager måske lidt længere tid for sc at slå igennem i row?

[svak]

7,2 % bedre end concensus er da vær at tage med

[peter12]

Det svarer til et recepttal for september på 247M ? Mon ikke det lugter af opjustering senere ?

[Helge_LarsenPI-redaktør]

J&J leverer bedre end ventet salg drevet af Darzalexhttps://www.proinvestor.com/investornyt/668541/jj-leverer-bedre-end-ventet-salg-drevet-af-darzalex-ny

[Bulder]

Hvad var Genmabs årsguidning? Var det ikke 3,9-4,2?

[E_L]

yes. i would not expect an upgrade in these uncertain times.

[Bulder]

If US repeats +19% in Q4, they will end in the very top of the interval.